IRIS - Res&Arch Institutional Research Information System - Research & Archive

LUDOVINI, VIENNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 566
EU - Europa 387
AS - Asia 186
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 564
IT - Italia 138
IE - Irlanda 120
SG - Singapore 77
HK - Hong Kong 42
CN - Cina 35
SE - Svezia 25
VN - Vietnam 25
DE - Germania 22
FR - Francia 17
FI - Finlandia 16
RU - Federazione Russa 16
RO - Romania 9
GB - Regno Unito 8
UA - Ucraina 7
KR - Corea 6
CH - Svizzera 4
AT - Austria 3
BO - Bolivia 1
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
MX - Messico 1
TR - Turchia 1
Totale 1.141
Salva come PNG Salva come JPEG
Città #
Chandler 168
Dublin 120
Perugia 67
Singapore 60
Boardman 47
Hong Kong 42
San Mateo 37
Santa Clara 32
Dong Ket 25
Altamura 22
Ann Arbor 21
Medford 21
Princeton 21
Lawrence 18
Munich 18
Andover 15
Redmond 14
Beijing 12
Helsinki 10
Bucharest 9
Dearborn 9
Saint Petersburg 6
San Paolo di Civitate 6
Wilmington 6
Seoul 5
Arezzo 4
Norwalk 4
Montalto delle Marche 3
Moscow 3
Redwood City 3
Rome 3
Vienna 3
Asso 2
Dallas 2
Houston 2
Los Angeles 2
New York 2
Paris 2
Ashburn 1
Baoding 1
Bologna 1
Cambridge 1
Chicago 1
Florence 1
Granarolo dell'Emilia e Viadagola 1
Guangzhou 1
Henderson 1
Izmir 1
Kiev 1
Lappeenranta 1
Lausanne 1
London 1
Marsciano 1
Ottawa 1
Padova 1
Reston 1
Seattle 1
Shijiazhuang 1
Sucre 1
Tianjin 1
Woodbridge 1
Totale 869
Salva come PNG Salva come JPEG
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 145
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 80
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 68
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 61
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 60
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy 59
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 58
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients 55
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 53
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 51
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 50
Liquid Biopsy in early Breast Cancer: A preliminary Report 50
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 49
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 45
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 44
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 41
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine 34
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients 33
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr 30
Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations 29
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 27
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 24
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer 22
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer 14
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases 13
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 12
Totale 1.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 0 3 6 1 10 10 26 5 1
2020/202192 1 3 7 0 32 6 1 4 6 2 3 27
2021/2022181 1 25 3 6 3 2 0 63 24 14 16 24
2022/2023438 21 84 5 54 39 30 0 21 163 3 15 3
2023/2024175 12 8 16 5 5 1 40 2 7 4 38 37
2024/2025153 7 35 42 16 53 0 0 0 0 0 0 0
Totale 1.207